TRIM31 and metabolic dysfunction-associated steatohepatitis: In conclusion, and of functional relevance, we determined that liver Trim31 expression correlated with NAFLD/NASH and metabolic disorder e.g., insulin resistance and glycometabolic disorder both in humans and in murine.